相关实验视频
Updated: Jul 4, 2026
07:58
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
13.8K
在不同常见癌症中对无细胞DNA的研究
Samira Nafar1, Kamran Hosseini2, Negin Shokrgozar3
1Medical Genetic Department, Shiraz University of Medical Science, Shiraz, Iran.
Molecular biotechnology
|December 10, 2023
概括
诊断癌症和血液恶性瘤至关重要. 液体活检中的无细胞DNA (cfDNA) 提供了用于癌症诊断的非侵入性方法,克服了传统侵入性技术的局限性.
科学领域:
- 在瘤学瘤学.
- 生物标志物 生物标志物
- 分子诊断学 分子诊断
背景情况:
- 准确的诊断对于管理癌症和血液恶性瘤至关重要.
- 目前的诊断方法往往是侵入性的,可能不会立即产生结果.
- 为了及时有效地检测癌症,需要非侵入性生物标志物.
研究的目的:
- 通过使用无细胞DNA (cfDNA) 审查和比较各种癌症的诊断方法.
- 突出cfDNA作为一种非侵入性预后生物标记物的潜力.
- 评估血清或血中cfDNA水平对于癌症诊断的有用性.
主要方法:
- 在癌症诊断中对cfDNA研究的文献综述.
- 在不同类型的癌症中,基于cfDNA的诊断方法的比较.
- 在血清或血样本中检测cfDNA的分析.
主要成果:
- 无细胞DNA (cfDNA) 分析是癌症诊断的一个有希望的非侵入性方法.
- 周围血液中的cfDNA水平显示出作为预后生物标志物的潜力.
- 该审查涵盖了肝细胞癌,肺癌,乳腺癌和血液恶性瘤中的应用.
结论:
- 使用cfDNA的液体活检是癌症诊断的宝贵的非侵入性工具.
- cfDNA分析比传统的侵入性方法具有优势.
- 对cfDNA诊断方法的进一步研究可以改善癌症管理.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...